Mostrar el registro sencillo del ítem

dc.contributor.authorVillelabeitia Jaureguizar, Koldobika 
dc.contributor.authorCalvo Lobo, César
dc.contributor.authorRodríguez-Sanz, David
dc.contributor.authorVicente Campos, Davinia 
dc.contributor.authorCastro-Portal, José Adrián
dc.contributor.authorLópez Cañadas, Marta
dc.contributor.authorBecerro-de-Bengoa-Vallejo, Ricardo
dc.contributor.authorLópez Chicharro, José
dc.date.accessioned2023-04-28T09:18:58Z
dc.date.available2023-04-28T09:18:58Z
dc.date.issued2022
dc.identifier.issn2227-9059spa
dc.identifier.urihttps://hdl.handle.net/10641/3373
dc.description.abstractWorldwide, healthcare systems had to respond to an exponential increase in COVID-19 patients with a noteworthy increment in intensive care units (ICU) admissions and invasive mechanical ventilation (IMV). The aim was to determine low intensity respiratory muscle training (RMT) effects in COVID-19 patients upon medical discharge and after an ICU stay with IMV. A retrospective case-series study was performed. Forty COVID-19 patients were enrolled and divided into twenty participants who received IMV during ICU stay (IMV group) and 20 participants who did not receive IMV nor an ICU stay (non-IMV group). Maximal expiratory pressure (PEmax), maximal inspiratory pressure (PImax), COPD assessment test (CAT) and Medical Research Council (MRC) dyspnea scale were collected at baseline and after 12 weeks of low intensity RMT. A greater MRC dyspnea score and lower PImax were shown at baseline in the IMV group versus the non-IMV group (p < 0.01). RMT effects on the total sample improved all outcome measurements (p < 0.05; d = 0.38–0.98). Intragroup comparisons after RMT improved PImax, CAT and MRC scores in the IMV group (p = 0.001; d = 0.94–1.09), but not for PImax in the non-IMV group (p > 0.05). Between-groups comparison after RMT only showed MRC dyspnea improvements (p = 0.020; d = 0.74) in the IMV group versus non-IMV group. Furthermore, PImax decrease was only predicted by the IMV presence (R2 = 0.378). Low intensity RMT may improve respiratory muscle strength, health related quality of life and dyspnea in COVID-19 patients. Especially, low intensity RMT could improve dyspnea level and maybe PImax in COVID-19 patients who received IMV in ICU.spa
dc.language.isoengspa
dc.publisherBiomedicinesspa
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectCOVID-19spa
dc.subjectRespiratory muscle trainingspa
dc.subjectInvasive mechanical ventilationspa
dc.subjectDyspneaspa
dc.titleLow Intensity Respiratory Muscle Training in COVID-19 Patients after Invasive Mechanical Ventilation: A Retrospective Case-Series Study.spa
dc.typejournal articlespa
dc.type.hasVersionAMspa
dc.rights.accessRightsopen accessspa
dc.description.extent545 KBspa
dc.identifier.doi10.3390/biomedicines10112807spa
dc.relation.publisherversionhttps://www.mdpi.com/2227-9059/10/11/2807spa


Ficheros en el ítem

FicherosTamañoFormatoVer
biomedicines-10-02807.pdf544.6KbPDFVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 España